CVS Health Corp. (CVS) Thursday announced it has expanded its flu and COVID-19 testing and treatment capabilities at approximately 1,600 CVS Pharmacy locations across 37 states.
Patients with flu-like symptoms can now receive a 3-in-1 combo test for Influenza A, Influenza B, and COVID-19 with a single swab.
In select states, including California, Illinois, and Washington, pharmacists can provide both testing and antiviral treatment during one appointment. Flu and COVID-19 tests cost $29.99, with pharmacist assessments priced at $45. CVS also offers at-home test kits and prescription delivery options. Updated flu and COVID-19 vaccines remain available at CVS Pharmacy and MinuteClinic locations nationwide.
CVS is currently trading at $64.72 up 1.35 percent or $0.86 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.